We pointed a microphone at our protein production and NMR labs and let the science speak for itself. Each sound you hear is a step within the same seamless integrated process: a plasmid transformed, a culture induced, a column eluting…
Using advanced synthetic strategies, our team designs and synthesizes complex peptides, delivering tools such as long and difficult peptide sequences, labelled peptides, and small proteins with synthetic or post-translational modifications.
Peptide drug discovery has entered a phase of unusual maturity and momentum, driven by the convergence of advanced display platforms, macrocyclic design, and early developability integration. Together, these capabilities are expanding access to target classes long considered difficult to address…
When a theranostic candidate reaches biodistribution studies, the analytical method is rarely the limiting factor, until it is. Fluorescence has artefacts. Radiolabeling has regulatory overhead. And conventional LC-MS/MS was not built for elemental analysis. The programs that move fastest are…
Covalent inhibitors have become a key strategy in drug discovery, offering advantages such as prolonged target engagement, high potency, and selectivity. However, identifying high-quality covalent binders requires well-designed fragment libraries and robust screening methodologies to ensure efficient hit-to-lead progression. At…
